Biotech

All Articles

Praxis epilepsy drug lowers confiscations in period 2 litigation

.Practice Preciseness Medicines has scored yet another midphase gain in epilepsy this year, with its...

Three directors resign as Dyne blog posts mixed information for DMD prospect

.After getting away from a clinical hold several years back, Dyne Therapy has actually disclosed new...

Arrowhead fires off stage 3 records in unusual metabolic illness in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has shown its give before a possible face-off with Ionis, posting stage 3...

Pfizer, Valneva present lyme health condition try successful for second enhancer

.Pfizer as well as Valneva may possess about 2 additional years to stand by prior to they produce th...

Fierce Biotech Managing Editor Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Let's dive into a discussion along with Ayla Ellison, Strong Biotech Editor-in-Chief and also Miche...

New information show how Bayer's asundexian failed to prevent strokes

.Bayer suspended the period 3 test for its own factor XIa prevention asundexian late in 2014 after t...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS trials

.Sanofi is actually still bented on taking its own various sclerosis (MS) med tolebrutinib to the FD...

Galapagos' stock up as fund reveals intent to shape its own advancement

.Galapagos is actually coming under extra pressure coming from investors. Having created a 9.9% conc...

Cell- centered Sana scoops initial CSO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of considerable management hirings, firings a...

Allist pays off Jacobio $21M, landing part in Chinese KRAS ethnicity

.Shanghai Allist Pharmaceuticals has actually bought itself a starring job in China's KRAS market, p...